Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertugliflozin in nonischemic cardiomyopathy
NCT04490681Phase 3Unknown
- Sponsor
- Yonsei University
- Start
- Aug 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ertugliflozin in non-ischemic cardiomyopathy (NICM), heart failure (HF), sponsored by Yonsei University. Status: unknown.
02
Drugs
ertugliflozin
03
Conditions
non-ischemic cardiomyopathy (NICM)heart failure (HF)
Beyond the preview
Go deeper on NCT04490681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04490681.